Maquart et al., 2005 - Google Patents
Matrikines in the regulation of extracellular matrix degradationMaquart et al., 2005
- Document ID
- 14244156572843231541
- Author
- Maquart F
- Bellon G
- Pasco S
- Monboisse J
- Publication year
- Publication venue
- Biochimie
External Links
Snippet
The term “matrikines” was coined for designating peptides liberated by partial proteolysis of extracellular matrix macromolecules, which are able to regulate cell activities. Among these peptides, some of them may modulate proliferation, migration, protease production, or …
- 230000006760 regulation of extracellular matrix disassembly 0 title description 3
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/484—Plasmin (3.4.21.7)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4813—Exopeptidases (3.4.11. to 3.4.19)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Maquart et al. | Matrikines in the regulation of extracellular matrix degradation | |
Wang et al. | Matrix metalloproteinases, vascular remodeling, and vascular disease | |
Nguyen et al. | Roles of matrix metalloproteinases in cutaneous wound healing | |
Gifford et al. | MT1-MMP-dependent cell migration: proteolytic and non-proteolytic mechanisms | |
Heljasvaara et al. | Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases | |
Karamanos et al. | Matrix modeling and remodeling: a biological interplay regulating tissue homeostasis and diseases | |
Tjäderhane et al. | Optimizing dentin bond durability: control of collagen degradation by matrix metalloproteinases and cysteine cathepsins | |
Del Buono et al. | Metalloproteases and tendinopathy | |
Jacob | Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions | |
Björklund et al. | Gelatinase-mediated migration and invasion of cancer cells | |
MacColl et al. | Matrix metalloproteinases as regulators of vein structure and function: implications in chronic venous disease | |
Zucker et al. | Membrane type-matrix metalloproteinases (MT-MMP) | |
Ntayi et al. | Elastin-derived peptides upregulate matrix metalloproteinase-2-ediated melanoma cell invasion through elastin-binding protein | |
Thomas et al. | Matrix metalloproteinases and oral cancer | |
Maquart et al. | An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity: implication in tumor invasion | |
Egeblad et al. | New functions for the matrix metalloproteinases in cancer progression | |
Chaudhary et al. | Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: an overview | |
Christiansen et al. | Effect of fibroblast activation protein and α2-antiplasmin cleaving enzyme on collagen types I, III, and IV | |
Pasco et al. | Control of melanoma progression by various matrikines from basement membrane macromolecules | |
Hornebeck et al. | Proteolyzed matrix as a template for the regulation of tumor progression | |
Chintala et al. | Invasion of human glioma: role of extracellular matrix proteins | |
Suojanen et al. | A novel and selective membrane type-1 matrix metalloproteinase (MT1-MMP) inhibitor reduces cancer cell motility and tumor growth | |
CA2323239C (en) | Novel matrix metalloproteinase inhibitors and down-regulators | |
Larjava et al. | Keratinocyte interactions with fibronectin during wound healing | |
Charvat et al. | Ras-transfection up-regulated HaCaT cell migration: inhibition by Marimastat |